LG41032-0
CefotetanSusc|Isolate
Active
Maturity: Beta
- The LOINC Groups project is a work in progress. The contents of this file may change from release to release as we receive feedback from users and refine our processes.
- The contents of the file and the groupings MUST be validated by the user prior to implementation in any aspect of clinical care. We have created Groups that may be useful in specific contexts, but these Groups have not been vetted for use in either patient care or research and should be used with caution.
- More information on LOINC Groups is available on our website.
Basic Attributes
- Version First Released
- Pending promotion to Production status (Beta)
- Parent Group
- LG99-4 IsolateSusc<SAME:Comp|Sys><ROLLUP:Tm|Prop|Method>
- Group Category
- Flowsheet - laboratory
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- ValueSet definition
- https:
//fhir.loinc.org/ValueSet/?url=http: //loinc.org/vs/LG41032-0 - ValueSet expansion
- https:
//fhir.loinc.org/ValueSet/$expand?url=http: //loinc.org/vs/LG41032-0
LOINC terms in Group
| LOINC | Long Common Name |
|---|---|
| 111-5 | cefoTEtan [Susceptibility] by Minimum lethal concentration (MLC) |
| 112-3 | cefoTEtan [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 113-1 | cefoTEtan [Susceptibility] by Disk diffusion (KB) |
| 18887-0 | cefoTEtan [Susceptibility] |
| 6990-6 | cefoTEtan [Susceptibility] by Gradient strip |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright